CFCThe Compounder Score

Financial statements are reported in CAD. Prices converted from USD at today's exchange rate. Tranches and alerts stay in USD.

Show values in
ISOLF logo

ISOLF — Isodiol International Inc.

Drug Manufacturers - Specialty & GenericHealthcare

CA$ 0.00

+CA$ 0.00 (+0.00%)

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds.

Market Cap

CA$ 7010.36

Forward P/E

N/A

52-Week Range

N/A

ISOLF Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

CA$ 19.1M

Revenue · FY2018

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

Annual. FCF margin is shown under each year.

No cash flow statement data available for this ticker yet.

Return on Capital Employed (ROCE)

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

No balance sheet data available to compute ROCE for this ticker yet.

Total Assets vs. Total Liabilities

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities
No balance sheet data available for this ticker yet.

CapEx as % of Revenue

Annual. Green at or under the 5% maximum target, red above it.

No cash flow statement data available for this ticker yet.

Shares Outstanding

49.1M

Diluted shares · FY2018

Only one year of share data is available, so no change can be shown yet.